Virtu Financial’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,832
Closed -$97K 2219
2025
Q4
$97K Buy
+48,832
New +$156K ﹤0.01% 1211
2025
Q2
Sell
-15,660
Closed -$23K 1985
2025
Q1
$23K Sell
15,660
-6,147
-28% -$15.5K ﹤0.01% 1091
2024
Q4
$51K Buy
+21,807
New +$383K ﹤0.01% 1159
2024
Q1
Sell
-49,128
Closed -$1.11M 2012
2023
Q4
$1.11M Buy
49,128
+26,824
+120% +$567K 0.09% 184
2023
Q3
$371K Buy
+22,304
New +$442K 0.04% 426
2023
Q1
Sell
-10,044
Closed -$297K 2031
2022
Q4
$297K Sell
10,044
-3,064
-23% -$110K 0.04% 501
2022
Q3
$548K Buy
+13,108
New +$354K 0.05% 355
2021
Q3
Sell
-8,667
Closed -$741K 1902
2021
Q2
$741K Sell
8,667
-27,004
-76% -$1.45M 0.07% 311
2021
Q1
$1.6M Buy
+35,671
New +$1.4M 0.11% 139
2019
Q3
Sell
-20,707
Closed -$25K 1786
2019
Q2
$25K Buy
20,707
+8,573
+71% +$9.72K ﹤0.01% 1320
2019
Q1
$16K Sell
12,134
-22,386
-65% -$25.7K ﹤0.01% 1301
2018
Q4
$29K Sell
34,520
-31,633
-48% -$36.4K ﹤0.01% 1339
2018
Q3
$67K Buy
66,153
+46,628
+239% +$70.9K ﹤0.01% 1264
2018
Q2
$40K Buy
+19,525
New +$167K ﹤0.01% 1795
2018
Q1
Sell
-15,866
Closed -$63K 2503
2017
Q4
$63K Buy
+15,866
New +$64.1K ﹤0.01% 2033

Other funds holding FLNA

Virtu Financial's FLNA Position: Q1 2026 in Review

Virtu Financial sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 48,832 shares — an estimated $97K sold.

Virtu Financial first reported a position in FLNA in Q4 2017 and held it in 15 quarters. The position peaked at $1.6M in Q1 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Virtu Financial reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 48,832 Filana Therapeutics shares in Q1 2026, an estimated $97K.
  • Virtu Financial first reported a position in Filana Therapeutics in Q4 2017 and held it in 15 quarters.
  • Virtu Financial's Filana Therapeutics position peaked at $1.6M in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.